Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Long-Term Debt Repayments (2020 - 2021)

Caribou Biosciences (CRBU) has disclosed Long-Term Debt Repayments for 2 consecutive years, with $119000.0 as the latest value for Q1 2021.

  • Quarterly Long-Term Debt Repayments changed N/A to $119000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $119000.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $119000.0 for FY2021, 5.31% up from the prior year.
  • Long-Term Debt Repayments for Q1 2021 was $119000.0 at Caribou Biosciences, up from $32000.0 in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $119000.0 in Q1 2021, with the low at $31000.0 in Q3 2020.